Therefore, our overall aim of this work was to identify, for the first time, the correlation between GSTs genetic polymorphisms and CML cancer risk, treatment response and pattern its interactions with smoking as genetic modifiers in the etiology of CML disease in the Iranian population. This evidence concerns the gene HPGDS and chronic myelogenous leukemia, BCR-ABL1 positive.